- Report
- May 2023
- 80 Pages
United Kingdom
From €2501EUR$2,595USD£2,151GBP
- Report
- May 2023
- 80 Pages
Russia
From €2501EUR$2,595USD£2,151GBP
- Report
- May 2023
- 80 Pages
Poland
From €2501EUR$2,595USD£2,151GBP
- Report
- May 2023
- 80 Pages
China
From €2501EUR$2,595USD£2,151GBP
- Report
- May 2023
- 80 Pages
Brazil
From €2501EUR$2,595USD£2,151GBP
- Report
- May 2023
- 80 Pages
Argentina
From €2501EUR$2,595USD£2,151GBP
- Report
- May 2024
- 50 Pages
Global
From €2554EUR$2,650USD£2,197GBP
- Report
- May 2024
- 50 Pages
Global
From €2554EUR$2,650USD£2,197GBP
- Report
- May 2024
- 50 Pages
Global
From €2554EUR$2,650USD£2,197GBP
- Report
- May 2024
- 25 Pages
Europe
From €1831EUR$1,900USD£1,575GBP
- Report
- May 2024
- 35 Pages
Europe
From €1831EUR$1,900USD£1,575GBP
- Report
- January 2022
- 210 Pages
Global
From €5943EUR$6,168USD£5,112GBP
- Report
- January 2022
- 168 Pages
Global
From €5943EUR$6,168USD£5,112GBP
- Report
- September 2020
- 278 Pages
Global
From €5943EUR$6,168USD£5,112GBP
- Report
- November 2023
- 173 Pages
Global
From €2697EUR$2,799USD£2,320GBP
- Report
- April 2023
- 147 Pages
Global
From €5781EUR$5,999USD£4,972GBP
- Book
- November 2022
- 352 Pages
Salicylic Acid is a common active ingredient in acne drugs, used to treat mild to moderate acne. It works by exfoliating the skin, unclogging pores, and reducing inflammation. It is available in a variety of forms, including creams, gels, lotions, and pads. It is often combined with other acne treatments, such as benzoyl peroxide, to provide a more comprehensive approach to acne treatment. Salicylic Acid is generally considered safe and effective, with few side effects.
The Salicylic Acid market is highly competitive, with many companies offering products containing the active ingredient. Some of the major players in the market include Johnson & Johnson, GlaxoSmithKline, Galderma, Stiefel Laboratories, and Allergan. Other companies, such as Cetaphil, Neutrogena, and La Roche-Posay, also offer products containing Salicylic Acid. Show Less Read more